C-reactive protein, leukocyte count and ESR in the assessment of severity of community-acquired pneumonia;Toplum kökenli pnömonilerin aǧirliǧinin deǧerlendirilmesinde C-reaktif protein lökosit sayisi ve eritrosit sedimentasyon hizinin yeri

Tuberkuloz ve Toraks

Volumn 54, Issue 1, 2006, Pages 22-29

  Bircan, Ahmet ^a   Kaya, Özlem ^a   Gökirmak, Münire ^a   Öztürk, Önder ^a   Şahin, Ünal ^a   Akkaya, Ahmet ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

C reactive protein; Community acquired pneumonia; Hospitalisation; Severity

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANAMNESIS; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OUTPATIENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED INFECTIONS; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MEDICAL RECORDS; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 33745491978     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ioachimescu OC, Ioachimescu AG, Iannini PB. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumonia: a 5-year experience. Int J Antimicrob Agents 2004; 24: 485-90.
2. British Thoracic Society Research Committee. Community-acquired pneumonia in adults in British hospitals in 1982-83: A survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987; 62: 195-220.
3. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1996; 275: 134-41.
4. Requilme R, Torres A, El-Elbiary M, et al. Community-acquired pneumonia in the elderly. A multivariate analysis of risk and prognostic factor. Am J Respir Crit Care Med 1996; 154: 1450-5.
5. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-54.
6. British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56 (Suppl IV): 1-64.
7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
8. Toraks Derneǧi. Erişkinlerde toplum kökenli pnömoni tani ve tedavi rehberi. Toraks Dergisi 2002; 3 (Ek 3): 1-15.
9. Stahl WM. Acute phase protein response to tissue injury. Crit Care Med 1987; 15: 545-50.
10. Vazquez GE, Martinez JA, Mensa J, et al. C-reactive protein levels in community-acquired pneumonia. Eur Respir J 2003; 21: 702-5.
11. Ay M, Gürbilek M, Vatansev H. Akut faz proteinleri. Genel Tip Dergisi 1998; 8: 125-32.
12. Castel JV, Gomez-Lechon MJ, David M, et al. Acute phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-86.
13. Hansson LO, Lindquist L. C-reactive protein: It's role in the diagnosis and follow-up of infectious diseases. Curr Opin Infect Dis 1997; 10: 196-201.
14. Almirall J, Bolibar I, Toran P, et al. Community-Acquired Pneumonia Maresme Study Group. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 2004; 125: 1335-42.
15. Lehtomaki K, Leinonen M, Takala A, et al. Etiological diagnosis of pneumonia in military conscripts by combined use of bacterial culture and serological methods. Eur J Clin Microbiol Infect Dis 1988; 7: 348-54.
16. Smith RP, Lipworth BJ. C-reactive protein in simple community-acquired pneumonia. Chest 1995; 107: 1028-31.
17. Ortqvist A, Hedlund J, Wretlind B, et al. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 1995; 27: 457-62.
18. Kolsuz M, Metintaş M, Uçgun I. Toplum kökenli pnömonilerde hastalik şiddeti ile akut faz proteinleri arasindaki ilişki. Tuberk Toraks 2002; 50: 431-7.
19. Ramsdell J, Narsavage GL, Fink JB; American College of Chest Physicians' Home Care Network Working Group. Management of community-acquired pneumonia in the home: An American College of Chest Physicians clinical position statement. Chest 2005; 127: 1752-63.
20. nd ed. Philadelphia: Mosby Inc, 2004: 273-88.
21. Özlü T. Yaşlilarda pnömoni. Numanoǧlu N, Topçu Willke A (editörler). Güncel Bilgiler Işiǧinda Pnömoniler. Ankara: Bilimsel Tip Yayinevi, 2000: 332-45.
22. Kadakal F, Yildiz P, Çetinkaya E ve ark. Toplum kökenli pnömoni: Ulusal uzlaşi raporuna göre olgularimizin deǧerlendirilmesi. Solunum Dergisi 2000; 2: 76-9.
23. Arbak P, Özdemir Ö, Erdem F ve ark. 1988-1994 yillari arasinda kliniǧimizde yatan toplum kökenli pnömoni olgulari. Tüberküloz ve Toraks Dergisi 1997; 45: 312-7.
24. Peltola H. C-reactive protein in rapid differantiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis; a preliminary report. J Pediatr 1983; 102: 773-5.
25. Appenzeller C, Ammann RA, Duppenthaler A, et al. Serum C-reactive protein in children with adenovirus infection. Swiss Med Wkly 2002; 132: 345-50.
26. Melbye H, Hvidsten D, Holm A, et al. The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract 2004; 54: 653-8.
27. Seppa Y, Bloigu A, Honkanen PO, et al. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med 2001; 161: 2709-13.
28. Mirette C, Guiterrez F, Masia M, et al. Usefulness of acute-phase proteins in community-acquired pneumonia. Med Clin (Barc) 2004; 122: 245-7.